Fish Paul V, Andrews Mark D, Jonathan Fray M, Stobie Alan, Wakenhut Florian, Whitlock Gavin A
Discovery Chemistry, Pfizer Global Research and Development, Sandwich Laboratories, Kent, UK.
Bioorg Med Chem Lett. 2009 May 15;19(10):2829-34. doi: 10.1016/j.bmcl.2009.03.090. Epub 2009 Mar 26.
Single enantiomer [(aryloxy)(pyridinyl)methyl]piperidine and pyrrolidine derivatives 5-9 are inhibitors of monoamine reuptake. Structure-activity relationships established that monoamine reuptake inhibition are functions of amine, pyridine isomer, aryloxy ring substitution and stereochemistry. Consequently, selective NRIs, selective SRIs, dual SNRIs and triple SNDRIs were all identified. Dual SNRIs 5l-a and 9c were evaluated in additional pharmacology and pharmacokinetic studies as representative examples from this series.
单一对映体[(芳氧基)(吡啶基)甲基]哌啶和吡咯烷衍生物5-9是单胺再摄取抑制剂。构效关系表明,单胺再摄取抑制作用是胺、吡啶异构体、芳氧基环取代和立体化学的函数。因此,鉴定出了选择性去甲肾上腺素再摄取抑制剂(NRIs)、选择性5-羟色胺再摄取抑制剂(SRIs)、双重5-羟色胺-去甲肾上腺素再摄取抑制剂(SNRIs)和三重5-羟色胺-去甲肾上腺素再摄取双重抑制剂(SNDRIs)。作为该系列的代表性实例,对双重SNRIs 5l-a和9c进行了额外的药理学和药代动力学研究。